Computational dreams and catmint schemes
At the Wellcome Sanger Institute, Xiaotian Liao navigates a world of protein puzzles, global experiences and furry friends, blending curiosity and computation into a journey that stretches far beyond the lab.
AI and genome engineering: new directions in biology
Dr Leopold Parts, Group Leader at the Wellcome Sanger Institute, studies the effects of DNA mutations by engineering variation in cells. After almost 10 years at Sanger, he has worked across different research areas and experienced significant changes in the field of biology. We spoke with Leo to hear his vision for the role of AI in enhancing gene editing and how it may revolutionise generative and synthetic genomics.
Prime Editing
Prime editing is the latest technique that enables scientists to alter the DNA of a living cell. It builds on CRISPR-Cas9 technology, and offers the potential to edit human cells to treat genetic diseases.
A lasting legacy
Meet the next generation of genomic scientists who are benefiting from our founder's generosity
Cracking cancer with CRISPR
How Sanger scientists are using genetic surgery to understand the blueprint of life
Human genome editing – the issues explored
Hayley Clissold from the Sanger Institute's policy team team explores the issues surrounding gene editing and human embryos
Claims of genome edited babies shock the world
Our Policy Lead, Sarion Bowers, explores the extraordinary claims that the world’s first genome edited babies have been born.
Human Embryo Editing: science fiction or science fact?
Anna Middleton, Head of the Society and Ethics research group at Wellcome Genome Campus Connecting Science, reports on Prof He Jiankiu's unverified announcement of gene editing the first human embryos that have been born
